Cancer Research Trust Fund Act
The source supplies the latest action, but no lifecycle stage.
Latest action (13 Aug 2026): Referred to the House Committee on Energy and Commerce.
What this bill does
This bill, H.R. 10093, proposes to create a "Cancer Research Trust Fund" within the U.S. Treasury. The fund would receive an amount equal to ten percent of the gross duties collected annually on imported tobacco and tobacco substitute articles. The Secretary of the Treasury would then transfer money from this fund to the Secretary of Health and Human Services.
The Secretary of Health and Human Services, in coordination with the Secretary of the Army and the Director of the Defense Health Agency, would use these funds for research and development in areas such as early cancer screening, prevention, treatments, and innovative therapies. Priority would be given to research on rare cancers and those affecting children.
The bill was introduced in the House of Representatives and has been referred to the Committee on Energy and Commerce. Its current status is "Introduced," meaning it has not yet been voted on or passed by either the House or the Senate.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
13 Aug 2026
Referred to the House Committee on Energy and Commerce.
Common questions
- What does H.R. 10093 do?
- This bill, H.R. 10093, proposes to create a "Cancer Research Trust Fund" within the U.S. Treasury. The fund would receive an amount equal to ten percent of the gross duties collected annually on imported tobacco and tobacco substitute articles. The Secretary of the Treasury would then transfer money from this fund to the Secretary of Health and Human Services. The Secretary of Health and Human Services, in coordination with the Secretary of the Army and the Director of the Defense Health Agency, would use these funds for research and development in areas such as early cancer screening, prevention, treatments, and innovative therapies. Priority would be given to research on rare cancers and those affecting children. The bill was introduced in the House of Representatives and has been referred to the Committee on Energy and Commerce. Its current status is "Introduced," meaning it has not yet been voted on or passed by either the House or the Senate.
- Has H.R. 10093 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 10093. Check the latest action and official source below.
- Who sponsored H.R. 10093?
- H.R. 10093 was sponsored by Rep. Hinson, Ashley [R-IA-2] (R-IA), with 0 cosponsors.
- What's the latest action on H.R. 10093?
- Referred to the House Committee on Energy and Commerce. (13 Aug 2026).
Related bills in Health
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Choices for Increased Mobility Act of 2026
Lower Premiums, Faster Payments Act
Access to Medical Supplies Act
More bills from Rep. Hinson, Ashley [R-IA-2]
LARC Access Expansion Act
Health Insurance Transparency for Patients Act
Protecting American Industry and Labor from International Trade Crimes Act of 2026
Protecting Financial Privacy Act of 2021
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.